|

Author:
Donald Saunders

The prostate gland forms part of the male reproductive system and is responsible for the production of a clear liquid which makes up about thirty percent of the seminal fluid used to carry and protect the male sperm during intercourse. The prostate gland sits just below the bladder and in front of the rectum, partially surrounding the urethra which carries urine from the bladder out of the body.

During childhood the prostate gland is very small (about the size of a pea) but will grow rapidly during puberty in response to the production of the male hormone testosterone. In a mature male the prostate is typically the size of a walnut and weighs about one ounce.

The prostate gland is divided into the three sections – peripheral, central and transition. The peripheral section is located at the rear of the prostate gland and is the section of the prostate in which prostatitis and prostate cancer are most likely to develop. The transition section, which lies in the middle of the prostate gland and surrounds the urethra, is the area in which benign prostatic hyperplasia (BPH) is seen.

There are a variety of problems associated with the prostate gland, the most common of which is BPH. This condition, which is a growth of non-cancerous cells within the transition section of the prostate gland causes an enlargement of the gland and exerts pressure on the urethra which, in turn, leads to difficulties in urinating. Other common problems include prostatitis, which is an inflammation or infection of the prostate gland, and prostate cancer.

Enlargement of the prostate gland will affect about half of all men by the time they reach the age of 60 and increases with age to affect some ninety percent of the male population by the age of 80. Prostate cancer will affect approximately seventeen percent of the male population and results in the deaths of over 30,000 men each year in the United States alone.

For further information on the prostate gland please visit Prostate Cancer Explained

| Translate/Traduisez/Übersetzen Sie/Traduzca/Traduca/Traduza: Article Keywords: The Prostate

A Quick Note From The Publisher... If you like the article above, you may be interested in the following article which is also related to The Prostate... The Risk of recurrence in prostate cancer Prostate cancer disease Prostate cancer - the most common form of cancer in men is Prostate cancer, the second leading cause of cancer death. The Main risk factors include age (incidence increases in men over the age of 65 years). It is more prevalent in the western world and about 10% of cases can be linked to family history. The recurrance Rate of the prostate cancer is high. Mostly, the Prostate cancer is a continuum; progressing through localized, locally advanced, advanced and hormone-refractory stages In general it is a slow growing cancer. He is primarily under hormonal control i.e. testosterone. The choice of treatments which include watchful waiting, surgery (prostatectomy), radiotherapy, hormonal therapy and chemotherapy are dependent on the stage of disease. 1. Most important, that If detected early, using PSA determination, DRE examination and biopsies, and treated appropriately, survival rates are excellent. 2. The most critical focus for the treatment of prostate cancer is to treat those cancers where it is necessary. 3. The Decisions about the best management of prostate cancer can be very complex and depend upon the: - Pathology of the cancer (unlike other cancers, prostate cancer often progresses very slowly) - The impact that treatment can have on quality of life, including sexual activity - Stage of the disease (non-metastatic (localized or locally advanced), metastatic or hormone refractory) - Age and general health of the patients at diagnosis - Patients preference for treatment - PSA at diagnosis 4. The treatment options for prostate cancer are: - Deferred treatment often called watchful waiting or 'active surveillance' - Surgery Radical Prostatectomy - Radiotherapy External Beam and/or Brachytherapy ...